Prenetics Spac

Prenetics will merge with a special purpose acquisition company SPAC in a deal that values the company at 125 billion to step up its attack on markets targeted by companies including 23andMe Exact Sciences and Invitae. HONG KONG Sept 16 Reuters - Hong Kong biotech company Prenetics will go public through a merger agreement with Artisan Acquisition a special purpose acquisition company SPAC valuing.

Softbank Backed E Commerce Giant Coupang Is Launching Ipo In 2021 Initial Public Offering Stock Advice Consolidation

Diabeloop joins corporate advisory partnership seeks to develop business in US.

Prenetics spac. Start-up that helped Premier League through 2020 lockdown becomes Hong Kongs first. Hong Kong biotech company Prenetics is set to merge with Artisan Acquisition a special purpose acquisition company backed by Hong Kong billionaire Adrian Cheng according to a source close to the deal. Has agreed to merge with tycoon Adrian Chengs US-listed blank-check company Artisan Acquisition CorpPrenetics has.

The deal to absorb Prenetics into the Nasdaq-listed Artisan Acquisition blank cheque company valued the genome and diagnostics biotech at 125bn. The deal to absorb Prenetics into the Nasdaq-listed Artisan Acquisition blank cheque company valued the genome and diagnostics biotech at 125bn. Hong Kong biotech company Prenetics is going public through a SPAC merger with Artisan Acquisition that will value the combined entity at 17 billion.

Caresyntax brings Series C funding to 130M. Tickets to Sports Concerts and more online now. Covid testing biotech Prenetics merges with US Spac in 125bn deal.

Prenetics a Covid-19 Testing Startup to Go Public in SPAC Merger Provider of PCR testing based in Hong Kong is set to merge with blank-check company. Along with the funds already raised by the Artisan Spac which shall be renamed Prenetics the deal offers the entity a mixed fairness worth of 17bn. In addition to the funds already raised by the Artisan Spac which will be renamed Prenetics.

Artisan Acquisition is backed by Adrian Cheng the CEO and Executive Vice Chairman of Hong Kong-listed New World Development a conglomerate with 88 billion in assets. Hong Kong-based Prenetics recently opened the Innovation Technology Centre for Advanced Molecular. Oxfords COVID diagnostics partner Prenetics eyeing 13B SPAC deal.

Ad Buy Tickets to Any Event at the Saratoga Performing Arts Center Online Here. Prenetics is set to merge with Artisan Acquisition a SPAC in a deal that will value the new entity at 13 billion or more a source told CNBC. The deal will make Prenetics.

Prenetics has an enterprise value of 125 billion in the deal to take it public according to a statement Thursday. In addition to the funds already raised by the Artisan Spac which will be renamed Prenetics the deal gives the entity a combined equity value of 17bn. The special purpose acquisition company or SPAC is also raising 120 million to.

Prenetics to go public in 125bn SPAC deal with Artisan. Prenetics is going public through a SPAC deal. The deal is expected to allow the Covid-19 testing startup to gain around 459m in cash including 339m of cash currently held.

The deal to soak up Prenetics into the Nasdaq-listed Artisan Acquisition clean cheque firm valued the genome and diagnostics biotech at 125bn. The SPAC trades on the Nasdaq under ARTAU. Bloomberg -- Hong Kong Covid-19 testing laboratory Prenetics Ltd.

Hong Kong-Based Prenetics to go Public via SPAC Sep 16 2021 staff reporter Save for later NEW YORK Genomic and diagnostic company Prenetics announced on Thursday that.

Stocks Jump As Wall Street Focuses On The Economy Reopening S P 500 Now Up 40 From March Low Nasdaq Stock Quotes Life Is Hard Quotes